Literature DB >> 23076147

Human IgA-binding peptides selected from random peptide libraries: affinity maturation and application in IgA purification.

Takaaki Hatanaka1, Shinji Ohzono, Mirae Park, Kotaro Sakamoto, Shogo Tsukamoto, Ryohei Sugita, Hiroyuki Ishitobi, Toshiyuki Mori, Osamu Ito, Koichi Sorajo, Kazuhisa Sugimura, Sihyun Ham, Yuji Ito.   

Abstract

Phage display system is a powerful tool to design specific ligands for target molecules. Here, we used disulfide-constrained random peptide libraries constructed with the T7 phage display system to isolate peptides specific to human IgA. The binding clones (A1-A4) isolated by biopanning exhibited clear specificity to human IgA, but the synthetic peptide derived from the A2 clone exhibited a low specificity/affinity (K(d) = 1.3 μm). Therefore, we tried to improve the peptide using a partial randomized phage display library and mutational studies on the synthetic peptides. The designed Opt-1 peptide exhibited a 39-fold higher affinity (K(d) = 33 nm) than the A2 peptide. An Opt-1 peptide-conjugated column was used to purify IgA from human plasma. However, the recovered IgA fraction was contaminated with other proteins, indicating nonspecific binding. To design a peptide with increased binding specificity, we examined the structural features of Opt-1 and the Opt-1-IgA complex using all-atom molecular dynamics simulations with explicit water. The simulation results revealed that the Opt-1 peptide displayed partial helicity in the N-terminal region and possessed a hydrophobic cluster that played a significant role in tight binding with IgA-Fc. However, these hydrophobic residues of Opt-1 may contribute to nonspecific binding with other proteins. To increase binding specificity, we introduced several mutations in the hydrophobic residues of Opt-1. The resultant Opt-3 peptide exhibited high specificity and high binding affinity for IgA, leading to successful isolation of IgA without contamination.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076147      PMCID: PMC3522307          DOI: 10.1074/jbc.M112.389742

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Streptococcal IgA-binding proteins bind in the Calpha 2-Calpha 3 interdomain region and inhibit binding of IgA to human CD89.

Authors:  R J Pleass; T Areschoug; G Lindahl; J M Woof
Journal:  J Biol Chem       Date:  2000-11-28       Impact factor: 5.157

Review 2.  Intestinal IgA synthesis: regulation of front-line body defences.

Authors:  Sidonia Fagarasan; Tasuku Honjo
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

3.  Comparison of multiple Amber force fields and development of improved protein backbone parameters.

Authors:  Viktor Hornak; Robert Abel; Asim Okur; Bentley Strockbine; Adrian Roitberg; Carlos Simmerling
Journal:  Proteins       Date:  2006-11-15

4.  Serum-free production and purification of chimeric IgA antibodies.

Authors:  T Beyer; S Lohse; S Berger; M Peipp; T Valerius; M Dechant
Journal:  J Immunol Methods       Date:  2009-05-07       Impact factor: 2.303

5.  Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.

Authors:  G Huls; I A Heijnen; E Cuomo; J van der Linden; E Boel; J G van de Winkel; T Logtenberg
Journal:  Cancer Res       Date:  1999-11-15       Impact factor: 12.701

6.  Recombinant human monoclonal igA antibody against CEA to recruit neutrophils to CEA-expressing cells.

Authors:  Jun Zhao; Motomu Kuroki; Hirotomo Shibaguchi; Lin Wang; Qun Huo; Noboru Takami; Toshihiro Tanaka; Tetsushi Kinugasa; Masahide Kuroki
Journal:  Oncol Res       Date:  2008       Impact factor: 5.574

7.  Isolation and detection of human IgA using a streptococcal IgA-binding peptide.

Authors:  Charlotta Sandin; Sara Linse; Thomas Areschoug; Jenny M Woof; Jesper Reinholdt; Gunnar Lindahl
Journal:  J Immunol       Date:  2002-08-01       Impact factor: 5.422

8.  Insights into IgA-mediated immune responses from the crystal structures of human FcalphaRI and its complex with IgA1-Fc.

Authors:  Andrew B Herr; Edward R Ballister; Pamela J Bjorkman
Journal:  Nature       Date:  2003-05-21       Impact factor: 49.962

9.  Effector mechanisms of recombinant IgA antibodies against epidermal growth factor receptor.

Authors:  Michael Dechant; Thomas Beyer; Tanja Schneider-Merck; Wencke Weisner; Matthias Peipp; Jan G J van de Winkel; Thomas Valerius
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

Review 10.  IgA Fc receptors.

Authors:  Renato C Monteiro; Jan G J Van De Winkel
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  8 in total

1.  Selection of Color-Changing and Intensity-Increasing Fluorogenic Probe as Protein-Specific Indicator Obtained via the 10BASE(d)-T.

Authors:  Masumi Taki; Hiroaki Inoue; Kazuto Mochizuki; Jay Yang; Yuji Ito
Journal:  Anal Chem       Date:  2016-01-06       Impact factor: 6.986

2.  Engineering an Affinity-Enhanced Peptide through Optimization of Cyclization Chemistry.

Authors:  Chayanon Ngambenjawong; Julio Marco B Pineda; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2016-11-10       Impact factor: 4.774

3.  Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond.

Authors:  Yong Ai; Lucia Hwang; Alexander D MacKerell; Ari Melnick; Fengtian Xue
Journal:  J Med Chem       Date:  2021-04-12       Impact factor: 7.446

4.  Strategic design to create HER2-targeting proteins with target-binding peptides immobilized on a fibronectin type III domain scaffold.

Authors:  Wanaporn Yimchuen; Tetsuya Kadonosono; Yumi Ota; Shinichi Sato; Maika Kitazawa; Tadashi Shiozawa; Takahiro Kuchimaru; Masumi Taki; Yuji Ito; Hiroyuki Nakamura; Shinae Kizaka-Kondoh
Journal:  RSC Adv       Date:  2020-04-17       Impact factor: 4.036

5.  Rationally designed mineralization for selective recovery of the rare earth elements.

Authors:  Takaaki Hatanaka; Akimasa Matsugami; Takamasa Nonaka; Hideki Takagi; Fumiaki Hayashi; Takao Tani; Nobuhiro Ishida
Journal:  Nat Commun       Date:  2017-05-26       Impact factor: 14.919

6.  IgY-binding peptide screened from a random peptide library as a ligand for IgY purification.

Authors:  Kamrul Hasan Khan; Arisa Himeno; Shouhei Kosugi; Yosuke Nakashima; Abdur Rafique; Ayana Imamura; Takaaki Hatanaka; Dai-Ichiro Kato; Yuji Ito
Journal:  J Pept Sci       Date:  2017-07-31       Impact factor: 1.905

Review 7.  IgA: Structure, Function, and Developability.

Authors:  Patrícia de Sousa-Pereira; Jenny M Woof
Journal:  Antibodies (Basel)       Date:  2019-12-05

Review 8.  Peptide Affinity Chromatography Applied to Therapeutic Antibodies Purification.

Authors:  Gabriela R Barredo-Vacchelli; Silvana L Giudicessi; María C Martínez-Ceron; Osvaldo Cascone; Silvia A Camperi
Journal:  Int J Pept Res Ther       Date:  2021-10-19       Impact factor: 1.931

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.